Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Wistar Institute's novel HIV vaccine receives funding for clinical trials

Sep. 4, 2007

Novel non-nucleoside HIV reverse transcriptase inhibitors profiled at Roche

Sep. 3, 2007

Novel therapeutic agents for HIV infection reported in GSK patents

Aug. 29, 2007

Vical reports results from a series of pDNA vaccine phase IIa trials for HIV

Aug. 27, 2007

Interim data from phase II trial of HIV vaccine tgAAC-09 reported by Targeted Genetics

Aug. 23, 2007

Rectally delivered HIV vaccine immunogenic in preclinical studies

Aug. 9, 2007

First approval for Pfizer's novel HIV treatment

Aug. 8, 2007

Novel inhibitors of HIV-1 protease dimerization described

Aug. 8, 2007

Interim results show improved lipid profiles in HIV patients treated with boosted Invirase

Aug. 7, 2007

New HIV Tat vaccine induces humoral and cell-mediated immune responses in mice

Aug. 7, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...